Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart Follow-Up plan stop suicide attempts?

NCT ID NCT01123174

Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a personalized follow-up plan (called ALGOS) for people who survived a suicide attempt. The goal was to see if this plan could reduce the number of people who try again within 6 months, compared to usual care. Over 1,000 adults took part, and researchers tracked suicide re-attempts, deaths, and costs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,040 people

The number who actually took part.

Start date

Feb 2010

Finished

Jul 2014

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Surviving to a suicide attempt (SA) directly leaving the Emergency unit or have been hospitalized less than 7 days Exclusion Criteria: * recidivists who made 4 SA and more in the 3 past years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicide, attempted are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Suicide, attempted

Contacts and locations

Locations

  • General Hospital, Boulogne sur Mer

    Boulogne-sur-Mer, France

  • General Hospital, Douai

    Douai, France

  • General Hospital, Dunkerque

    Dunkirk, France

  • General Hospital, Montauban

    Montauban, France

  • General Hospital, Quimper

    Quimper, France

  • General Hospital, Roubaix

    Roubaix, France

  • General Hospital, Tourcoing

    Tourcoing, France

  • General Hospital, Vannes

    Vannes, France

  • Georges Pompidou European Hospital, Paris

    Paris, France

  • Health Centre Henin Beaumont

    Hénin-Beaumont, France

  • Henri Mondor Hospital, Creteil

    Créteil, France

  • University Hospital, Angers

    Angers, France

  • University Hospital, Brest

    Brest, France

  • University Hospital, Caen

    Caen, France

  • University Hospital, Clermont Ferrand

    Clermont-Ferrand, France

  • University Hospital, Lille

    Lille, 59037, France

  • University Hospital, Marseille

    Marseille, France

  • University Hospital, Montpellier

    Montpellier, France

  • University Hospital, Nancy

    Nancy, France

  • University Hospital, Nantes

    Nantes, France

  • University Hospital, Nice

    Nice, France

  • University Hospital, Rennes

    Rennes, France

  • University Hospital, Toulouse

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.